White label ELPA - ClinicalTrials.eu

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
- Ibrutinib
- Venetoclax
Study of Pembrolizumab and Olaparib for Patients with Advanced Colorectal Cancer with DNA Repair Deficiency

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer
Investigated Drugs:
- Olaparib
- Pembrolizumab
Study on ADP-A2M4CD8 and Nivolumab for Patients with Recurrent Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer recurrent
Investigated Drugs:
- Autologous T Cells Expressing Cd8A And A T-Cell Receptor Targeting Mage-A4
- Nivolumab
Study on FOLFOX and Docetaxel for Patients with Advanced or Metastatic Stomach and Esophagus Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Oesophageal adenocarcinoma
Investigated Drugs:
Study of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
+3
Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine

Not recruiting

3 1 1 1
Investigated Drugs:
Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
+5
Study on Long-Term Safety and Efficacy of ARO-APOC3 for Adults with Mixed Dyslipidemia

Not recruiting

2 1 1
Investigated Diseases:
- Type V hyperlipidaemia
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Not recruiting

2 1 1 1
Investigated Drugs:
- Azacitidine
- Venetoclax
Study on CTL-002 and Nivolumab for Patients with Advanced-Stage, Relapsed/Refractory Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies